Mergers: Commission approves GlaxoSmithKline’s acquisition of Pfizer’s Consumer Health Business, subject to conditions

drugs

(Joshua Coleman, Unsplash)

This article is brought to you in association with the European Commission.


The European Commission has approved, under the EU Merger Regulation, the acquisition of Pfizer’s Consumer Health Business by GlaxoSmithKline. The decision is conditional upon the global divestment of Pfizer’s topical pain management business carried out under the ThermaCare brand.

GlaxoSmithKline (“GSK”) and Pfizer’s Consumer Health Business are both manufacturers and suppliers of a variety of consumer healthcare pharmaceuticals, which are typically available to patients without a prescription from a doctor and generally referred to as “over-the-counter” (“OTC”) pharmaceutical products.

Both companies are active in the European Economic Area (“EEA”) in a number of OTC product categories, namely topical pain management (creams, gels, spays and patches to treat pain locally), systemic pain management (products for oral intake targeting pain centrally), cold and flu treatments (e.g. multi-symptom treatments, antitussives), gastrointestinal treatments (e.g. antiacids, antiflatulents, antiulcerants), nutrition and digestive health (e.g. vitamins, supplements, laxatives), as well as sedatives and sleeping aids.

The Commission’s investigation

The Commission examined the effects of the proposed transaction on competition in the markets where the activities of the companies overlap.

Based on the investigation, the Commission was concerned that the acquisition would reduce competition for topical pain management products, possibly resulting in price increases in a number of EEA countries, including Austria, Germany, Ireland, Italy and the Netherlands.

In the market for topical pain management products,the Commission found products to be broadly substitutable irrespective of their different format or composition (e.g. patches and gels, medicated or not).

For topical pain management products, GSK is a leading OTC supplier in the EEA with its range of Volta-branded products (including VoltarenVoltadol, or Voltarol). These products are mainly sold as medicated gel, creams or spray but also as medicated and non-medicated patches. Pfizer is mostly active in the EEA with its range of ThermaCare-branded products, which consists mainly of non-medicated patches.

The proposed remedies

To address these concerns, the companies offered to divest Pfizer’s topical pain management business carried out under the ThermaCarebrand globally. This includes all relevant assets that contribute to the current operation or are necessary to ensure the viability and competitiveness thereof.

These assets will have to be divested as a package to one suitable purchaser to be approved by the Commission. The commitments provide in particular for the divestiture of a Pfizer manufacturing facility located in the US, which is dedicated to the production of ThermaCare products, of all intellectual property rights relating to the ThermaCare products and brand, as well as products under development.

These commitments remove almost entirely the overlaps between GSK and Pfizer’s Consumer Health Business in the topical pain management category in the EEA.

Therefore, the Commission concluded that the proposed transaction, as modified by the commitments, would no longer raise competition concerns in the EEA. The Commission’s decision is conditional upon full compliance with the commitments.

Companies and products

GSK, based in the UK, is a pharmaceuticals company active worldwide in research, development, manufacturing, and marketing in three broad segments, i.e. prescription pharmaceuticals, vaccines, and consumer healthcare products.

Pfizer, based in the US, is a pharmaceuticals company active worldwide in the research, development, manufacturing and marketing of innovative medicines. Pfizer’s Consumer Health Businessoffers products in five major areas: (a) pain management; (b) gastrointestinal health; (c) respiratory; (d) dietary supplements, and (e) personal care products (e.g. lip care).

Merger control rules and procedures

The transaction was notified to the Commission on 17 May 2019.

The Commission has the duty to assess mergers and acquisitions involving companies with a turnover above certain thresholds (see Article 1 of the Merger Regulation) and to prevent concentrations that would significantly impede effective competition in the EEA or any substantial part of it.

The vast majority of notified mergers do not pose competition problems and are cleared after a routine review. From the moment a transaction is notified, the Commission generally has a total of 25 working days to decide whether to grant approval (Phase I) or to start an in-depth investigation (Phase II). This deadline is extended to 35 working days in cases where remedies are submitted by the parties, such as in this case.

the sting Milestones

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

No way out for Eurozone’s stagnating economy

COVID-19 lockdown hits working mothers harder than fathers

Global aid appeal targets more than 93 million most in need next year

The Commission favours the cultivation of more GMOs in Europe

Eurozone close to agreeing on a Banking Union

Boeing WTO case: The EU puts in place countermeasures against U.S. exports

GSMA outlines new developments for Mobile World Congress Shanghai 2018

“Only through energy policy we can trigger competitiveness”. The Sting live from #EBS2015: Energy Union – When will it happen?

The COP22 is under full deployment while Donald Trump threatens openly to withdraw the US from the Paris agreement

What cryptocurrencies will do to the integrity of politics

He died so I could live: UN peacekeeper pays tribute to fallen colleague

New tech infrastructure will help economies recover after COVID-19

We can’t tell if we’re closing the digital divide without more data

Embracing technology as a service will fuel the circular economy. Here’s how.

Migration situation at the Greek-Turkish border: ensuring the right to asylum

Airships, solar planes and Soviet-era sea skimmers … here’s how we fix air travel

The EU spent €158 billion on vague, open-ended rural projects

The Parliament sets the way for the European Banking Union

The challenge to be a good healthcare professional

Intel @ European Business Summit 2014: Better decisions now, the new business dashboard 

‘The time for action is now’ senior UN peacekeeping official says, urging support for regional force combating Sahel terrorism

Europe turns out more jobs this summer

EU-U.S. Privacy Shield: Second review shows improvements but a permanent Ombudsperson should be nominated by 28 February 2019

Asylum: MEPs call for more solidarity among EU member states

Why and How: Advocating for the inclusion of Palliative Care in Universal Health Care

The European Parliament declares climate emergency

EU citizens want more competences for the EU to deal with crises like COVID-19

Further reforms in Japan needed to meet the challenges of population ageing and high public debt

EU budget deal struck with Parliament negotiators

China Unlimited: the dragon’s long and winding road

Why precision medicine won’t transform healthcare – but governance could

A 10-step plan to save our seas

Is this a turning point in the fight against slavery?

‘No safe way’ into battle-scarred Afghan city of Ghazni to deliver aid as traumatized children search for parents

The new era of Matriarchy?

Why the 21st century’s biggest health challenge is our shared responsibility

Top global firms commit to tackling inequality by joining Business for Inclusive Growth coalition

Estonia is making public transport free

Why embracing human rights will ensure Artificial Intelligence works for all

The financial world upside-down: debt failure closer

Rise in violent conflict shows prevention ‘more necessary than ever’: UN chief

Sweden is fighting loneliness by housing older and younger generations together

Joint advocacy letter template to sign and ratify the Treaty on the Prohibition of Nuclear Weapons

Quicker freezing and confiscation of criminal assets to fight organised crime

Five years on from ISIL ‘caliphate’ proclamation in Iraq, Security Council makes first-ever visit

End racist discrimination against Afro-European people in the EU

Deal on EU funds for common asylum, migration and integration policies up to 2027

Climate change is threatening Switzerland’s stunning scenery

Global spotlight on world drug problem ‘is personal’ for many families, says UN chief

Dare to be vulnerable, and three other lessons in leadership

Two States ‘side-by-side’ is the ‘peaceful and just solution’ for Israel-Palestine conflict: Guterres

How do we upskill a billion people by 2030? Leadership and collaboration will be key

November infringements package: key decisions

Capitalism’s greatest weakness? It confuses price with value

End ‘political opportunism’ that’s letting hate speech flourish, urges top UN genocide official

Security Council discusses chemical weapons use in Syria following latest global watchdog report

Safe spaces offer security and dignity for youth, and help make the world ‘better for all’: Guterres

Change is happening – and young people are leading the way forward

Which country offers the cheapest mobile data?

Finnish Council Presidency priorities debated in plenary

More Stings?

Advertising

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s